首页 | 本学科首页   官方微博 | 高级检索  
     


Possible effects of lipoprotein-associated phospholipase A2 single-nucleotide polymorphisms on cardiovascular risk in patients with preeclampsia
Authors:Zeynep B. Güngör  Abdullah Tüten  Hakan Ekmekçi  Özlem B. Ekmekçi  Mine Kucur  Mahmut Öncül
Affiliation:1. Department of Medical Biochemistry, Cerrahpasa Medical School, University of Istanbul, Istanbul, Turkey;2. Department of Obstetrics and Gynecology, Cerrahpasa Medical School, University of Istanbul, Istanbul, Turkey
Abstract:Purpose: Lipoprotein lipase-associated phospholipase A2 (Lp-PLA2) is a vascular inflammatory marker associated with cardiovascular diseases (CVD). Women with preeclampsia (PE) have elevated vascular inflammation and at higher CVD risk in the later life. We hypothesize that vascular inflammation related genetic variations increase the risk for developing future cardiovascular disease in women with PE. To test this hypothesis, we studied PLA2G7 gene polymorphisms, Lp-PLA2 mass, activity, index, and other cardiovascular risk factors in women with preeclampsia.

Methods: A total of 200 pregnant women were included into the study. We stratified the PE group: early (28.7?±?3.0 weeks) and late onset (36.0?±?1.4 weeks). Serum Lp-PLA2 mass in the early PE and the late PE group were significantly higher than the control group (p?=?.000). Lp-PLA2 index, Hs-C-reactive protein (CRP), serum amyloid A (SAA), calprotectin, and PTX3 levels were higher in early and late PE (p?=?.000). Single-nucleotide mutations of PLA2G7 rs1805017 (r?=??0.228, p?r?=?0.216, p?Conclusions: Lp-PLA2 genetic variability with vascular inflammatory markers might contribute the incidence of future cardiovascular events.
Keywords:Lp-PLA2 mass  Lp-PLA2 SNP  preeclampsia  PTX3  vascular inflammation
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号